Anders Tuv Overview

  • Primary Position
  • Chief Investment...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 8

  • Med. Deal Size

  • Med. Valuation

Anders Tuv General Information

Biography

Mr. Anders Tuv serves as Investment Director at The Norwegian Radium Hospital Research Foundation. He serves as a Board Member, Chair of the Audit Committee, and Member of the Remuneration Committee at Nykode. He serves as Board Member at Photocure, Simli, and ARTBIO. He serves as Chief Investment Officer at Radforsk Investeringsstiftelse. He serves as Chairman at Vaccibody. He serves as Board Member at ClexBio. He serves as the Chairman of the Nomination Committee at the Oslo Cancer Cluster. He served as Advisor at Norwegian Mycelium. He also serves as Board Member at OnDosis, He serves Board Member at Zelluna and Nextera. He served as the Chairman at OncoImmunity. He is the investment director of the early-stage life science investment company Radforsk, which is focused on immunotherapies and precision medicines. He is an experienced investment and business development professional with broad experience in the life science industry covering management positions, strategy, and business development, research collaborations, licensing deals, M&A, and IPOs. He holds several chairmen and non-executive director positions in Norwegian biotech companies. He holds an MBE degree.

Contact Information

Primary Position
Chief Investment Officer, Radforsk Investeringsstiftelse
Gender
Male
Total Investments
Email
an
Address
  • Ullernchausseen 64
  • 0379 Oslo
  • Norway

Anders Tuv Positions (3)

Firm name Firm type Title Location Industry Since
ARTBIO Company Co-Founder & Board Observer Cambridge, MA Biotechnology
Radforsk Investeringsstiftelse Investor Chief Investment Officer Oslo, Norway Venture Capital
Zelluna Immunotherapy Company Co-Founder & Board Member Oslo, Norway Drug Discovery

Anders Tuv Board Seats (8)

Company Industry Ownership Status Financing Status Location Since
ARTBIO Biotechnology Privately Held (backing) Venture Capital-Backed Cambridge, MA
Circio Biotechnology Publicly Held Formerly VC-backed Oslo, Norway
ClexBio Biotechnology Privately Held (backing) Venture Capital-Backed Oslo, Norway
Nextera Drug Discovery Privately Held (backing) Venture Capital-Backed Oslo, Norway
Nykode Biotechnology Publicly Held Formerly VC-backed Oslo, Norway

Anders Tuv Lead Partner on Deals (6)

Anders Tuv has been the lead partner on 6 deals. Their latest deal was with ARTBIO, a biotechnology company. The deal was made for on 21-Jun-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
ARTBIO 21-Jun-2023 Seed Round Completed Biotechnology Cambridge, MA
NoMy 15-Apr-2022 Completed Biotechnology Oslo, Norway
Photocure 25-Jun-2020 Completed Pharmaceuticals Oslo, Norway
Zelluna Immunotherapy 01-Jan-2016 Completed Drug Discovery Oslo, Norway
Nextera 19-Aug-2012 Early Stage VC Completed Drug Discovery Oslo, Norway
Nykode 30-Jul-2012 Early Stage VC Completed Biotechnology Oslo, Norway

Anders Tuv Network (107)

Board Members (55)

Name Company Representing Location From
Erlend Skagseth Nykode Sarsia Management Oslo, Norway
Gustav Gaudernack Zelluna Immunotherapy Self Oslo, Norway
OnDosis GU Ventures Molndal, Sweden
Zelluna Immunotherapy Self Oslo, Norway
Nykode Self Oslo, Norway

Portfolio Executives (52)

Name Company Role Deal date Location
Philippe Dasse ARTBIO Chief Technical Officer 21-Jun-2023 Cambridge, MA
Emanuele Ostuni Ph.D ARTBIO Founding Chief Executive Officer & Board Member 21-Jun-2023 Cambridge, MA
ARTBIO Vice President of Finance & Finance Director 21-Jun-2023 Cambridge, MA
ARTBIO Sceintific Co-Founder & Scientific Advisory Board Member 21-Jun-2023 Cambridge, MA
ARTBIO Vice President of Clinical Development 21-Jun-2023 Cambridge, MA

Anders Tuv FAQs

  • Who is Anders Tuv?

    Mr. Anders Tuv serves as Investment Director at The Norwegian Radium Hospital Research Foundation.

  • How much does Anders Tuv typically invest?

    Anders Tuv's median deal size is .

  • What is Anders Tuv’s main position?

    Anders Tuv’s primary position is Chief Investment Officer.

  • How many active board seats does Anders Tuv hold?

    Anders Tuv holds 8 board seats including ARTBIO, Circio, ClexBio, Nextera, and Nykode.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »